Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeWages, Salaries and Other
Others
Ratios

Armata Pharmaceuticals (ARMP) Revenue (2016 - 2018)

Armata Pharmaceuticals (ARMP) has disclosed Revenue for 6 consecutive years, with -$324000.0 as the latest value for Q4 2018.

  • Quarterly Revenue fell 1720.0% to -$324000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was -$912000.0 through Dec 2018, down 893.04% year-over-year, with the annual reading at -$11.7 million for FY2025, 109.88% down from the prior year.
  • Revenue hit -$324000.0 in Q4 2018 for Armata Pharmaceuticals, down from -$307000.0 in the prior quarter.
  • In the past five years, Revenue ranged from a high of $143000.0 in Q3 2015 to a low of -$324000.0 in Q4 2018.
  • Historically, Revenue has averaged $18263.2 across 5 years, with a median of $101000.0 in 2014.
  • Biggest five-year swings in Revenue: surged 3333.33% in 2014 and later crashed 1720.0% in 2018.
  • Year by year, Revenue stood at $101000.0 in 2014, then rose by 26.73% to $128000.0 in 2015, then plummeted by 82.81% to $22000.0 in 2016, then dropped by 9.09% to $20000.0 in 2017, then plummeted by 1720.0% to -$324000.0 in 2018.
  • Business Quant data shows Revenue for ARMP at -$324000.0 in Q4 2018, -$307000.0 in Q3 2018, and -$281000.0 in Q2 2018.